Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taro Azelaic Acid Foam vs Finacea in Moderate Facial Rosacea
NCT03689010Phase 1Completed
- Start
- Dec 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Azelaic acid in rosacea (3 arms). Primary endpoint: Change in inflammatory lesion counts at 12 weeks. Started Dec 2017; status: completed.
02
Drugs
Azelaic acid
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT03689010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03689010.